Advertisement

Index by author

June 01, 2001; Volume 29,Issue 6

A

  1. Agrawal, Nancy

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  2. Akira, Kazuki

    1. Direct Nuclear Magnetic Resonance Spectroscopic Analysis of 13C-Labeled Antipyrine Metabolites in Human Urine
      Kazuki Akira, Eiji Negishi, Misako Imachi and Takao Hashimoto
      Drug Metabolism and Disposition June 2001, 29 (6) 903-907;

  3. Albert, Klaus

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

  4. Aldous, Kenneth M.

    1. CYP1B1 Expression in Human Lung
      Simon D. Spivack, Gregory J. Hurteau, Andrew A. Reilly, Kenneth M. Aldous, Xinxin Ding and Laurence S. Kaminsky
      Drug Metabolism and Disposition June 2001, 29 (6) 916-922;

  5. Aoyama, Takao

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

B

  1. Baillie, Thomas A.

    1. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  2. Beydon, Dominique

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;
    2. Toxicokinetics and Metabolism of 1,2-Diethylbenzene in Male Sprague Dawley Rats—Part 2: Evidence for in Vitro and in Vivo Stereoselectivity of 1,2-Diethylbenzene Metabolism
      Jean Paul Payan, Benoit Cossec, Dominique Beydon, Jean Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition June 2001, 29 (6) 868-876;

  3. Bhat, Vadiraja B.

    1. Effect of Ring Size in R-(+)-Pulegone-Mediated Hepatotoxicity: Studies on the Metabolism ofR-(+)-4-Methyl-2-(1-Methylethylidene)-Cyclopentanone anddl-Camphorone in Rats
      Hirekodathakallu V. Thulasiram, Vadiraja B. Bhat and Madhava K. Madyastha
      Drug Metabolism and Disposition June 2001, 29 (6) 821-829;

  4. Blizard, D.

    1. Mechanism of Induction of Cytochrome P450 Enzymes by the Proestrogenic Endocrine Disruptor Pesticide-Methoxychlor: Interactions of Methoxychlor Metabolites with the Constitutive Androstane Receptor System
      D. Blizard, T. Sueyoshi, M. Negishi, S. S. Dehal and D. Kupfer
      Drug Metabolism and Disposition June 2001, 29 (6) 781-785;

  5. Bolton, Judy L.

    1. Bioactivation of Tamoxifen to Metabolite E Quinone Methide: Reaction with Glutathione and DNA
      Peter W. Fan and Judy L. Bolton
      Drug Metabolism and Disposition June 2001, 29 (6) 891-896;

  6. Boudry, Isabelle

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

  7. Breyer-Pfaff, Ursula

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

C

  1. Canel, Francine

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

  2. Carmella, Steven G.

    1. Consumption of Watercress Fails to Alter Coumarin Metabolism in Humans
      Sharon E. Murphy, Lisa M. Johnson, London M. Losey, Steven G. Carmella and Stephen S. Hecht
      Drug Metabolism and Disposition June 2001, 29 (6) 786-788;

  3. Casciano, Christopher N.

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

  4. Chen, Qing

    1. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  5. Clement, Robert P.

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

  6. Cossec, Benoit

    1. Toxicokinetics and Metabolism of 1,2-Diethylbenzene in Male Sprague Dawley Rats—Part 2: Evidence for in Vitro and in Vivo Stereoselectivity of 1,2-Diethylbenzene Metabolism
      Jean Paul Payan, Benoit Cossec, Dominique Beydon, Jean Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition June 2001, 29 (6) 868-876;

D

  1. Dachtler, Markus

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

  2. Dehal, S. S.

    1. Mechanism of Induction of Cytochrome P450 Enzymes by the Proestrogenic Endocrine Disruptor Pesticide-Methoxychlor: Interactions of Methoxychlor Metabolites with the Constitutive Androstane Receptor System
      D. Blizard, T. Sueyoshi, M. Negishi, S. S. Dehal and D. Kupfer
      Drug Metabolism and Disposition June 2001, 29 (6) 781-785;

  3. Ding, Xinxin

    1. CYP1B1 Expression in Human Lung
      Simon D. Spivack, Gregory J. Hurteau, Andrew A. Reilly, Kenneth M. Aldous, Xinxin Ding and Laurence S. Kaminsky
      Drug Metabolism and Disposition June 2001, 29 (6) 916-922;

E

  1. Elfarra, Adnan A.

    1. Metabolism of Butadiene Monoxide by Freshly Isolated Hepatocytes from Mice and Rats: Different Partitioning between Oxidative, Hydrolytic, and Conjugation Pathways
      Raymond A. Kemper, Renee J. Krause and Adnan A. Elfarra
      Drug Metabolism and Disposition June 2001, 29 (6) 830-836;

  2. Engel, Jürgen

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

F

  1. Fabry, Jean-Paul

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

  2. Fabry, Jean Paul

    1. Toxicokinetics and Metabolism of 1,2-Diethylbenzene in Male Sprague Dawley Rats—Part 2: Evidence for in Vitro and in Vivo Stereoselectivity of 1,2-Diethylbenzene Metabolism
      Jean Paul Payan, Benoit Cossec, Dominique Beydon, Jean Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition June 2001, 29 (6) 868-876;

  3. Fan, Peter W.

    1. Bioactivation of Tamoxifen to Metabolite E Quinone Methide: Reaction with Glutathione and DNA
      Peter W. Fan and Judy L. Bolton
      Drug Metabolism and Disposition June 2001, 29 (6) 891-896;

  4. Farrell, Dorothy E.

    1. Identification of Multiple Constitutive and Inducible Hepatic Cytochrome P450 Enzymes in Market Weight Swine
      Michael J. Myers, Dorothy E. Farrell, Karyn D. Howard and Joseph C. Kawalek
      Drug Metabolism and Disposition June 2001, 29 (6) 908-915;

  5. Favreau, Leonard V.

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

  6. Ferrari, Elisabeth

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;
    2. Toxicokinetics and Metabolism of 1,2-Diethylbenzene in Male Sprague Dawley Rats—Part 2: Evidence for in Vitro and in Vivo Stereoselectivity of 1,2-Diethylbenzene Metabolism
      Jean Paul Payan, Benoit Cossec, Dominique Beydon, Jean Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition June 2001, 29 (6) 868-876;

  7. Fujii, Toshihiko

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  8. Funae, Yoshihiko

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

G

  1. Gaertner, Ines

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

  2. Geer, Leslie A.

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  3. Grandclaude, Marie-Christine

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

  4. Groothuis, Geny M. M.

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

H

  1. Halpin, Rita A.

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  2. Hasegawa, Masatoshi

    1. Identification of Rat Urinary and Biliary Metabolites of Esonarimod, a Novel Antirheumatic Drug, Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry with Postcolumn Addition of 2-(2-Methoxyethoxy)Ethanol, a Signal-Enhancing Modifier
      Jun-Ichi Yamaguchi, Mari Ohmichi, Masatoshi Hasegawa, Hideo Yoshida, Naoyoshi Ogawa and Shohei Higuchi
      Drug Metabolism and Disposition June 2001, 29 (6) 806-812;

  3. Hashimoto, Takao

    1. Direct Nuclear Magnetic Resonance Spectroscopic Analysis of 13C-Labeled Antipyrine Metabolites in Human Urine
      Kazuki Akira, Eiji Negishi, Misako Imachi and Takao Hashimoto
      Drug Metabolism and Disposition June 2001, 29 (6) 903-907;

  4. Hashizume, Takanori

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  5. Hecht, Stephen S.

    1. Consumption of Watercress Fails to Alter Coumarin Metabolism in Humans
      Sharon E. Murphy, Lisa M. Johnson, London M. Losey, Steven G. Carmella and Stephen S. Hecht
      Drug Metabolism and Disposition June 2001, 29 (6) 786-788;

  6. Hempel, Roland

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

  7. Hermann, Robert

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

  8. Higuchi, Shohei

    1. Identification of Rat Urinary and Biliary Metabolites of Esonarimod, a Novel Antirheumatic Drug, Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry with Postcolumn Addition of 2-(2-Methoxyethoxy)Ethanol, a Signal-Enhancing Modifier
      Jun-Ichi Yamaguchi, Mari Ohmichi, Masatoshi Hasegawa, Hideo Yoshida, Naoyoshi Ogawa and Shohei Higuchi
      Drug Metabolism and Disposition June 2001, 29 (6) 806-812;

  9. Ho, Chi-Tang

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  10. Howard, Karyn D.

    1. Identification of Multiple Constitutive and Inducible Hepatic Cytochrome P450 Enzymes in Market Weight Swine
      Michael J. Myers, Dorothy E. Farrell, Karyn D. Howard and Joseph C. Kawalek
      Drug Metabolism and Disposition June 2001, 29 (6) 908-915;

  11. Hurteau, Gregory J.

    1. CYP1B1 Expression in Human Lung
      Simon D. Spivack, Gregory J. Hurteau, Andrew A. Reilly, Kenneth M. Aldous, Xinxin Ding and Laurence S. Kaminsky
      Drug Metabolism and Disposition June 2001, 29 (6) 916-922;

I

  1. Iga, Tatsuji

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

  2. Imachi, Misako

    1. Direct Nuclear Magnetic Resonance Spectroscopic Analysis of 13C-Labeled Antipyrine Metabolites in Human Urine
      Kazuki Akira, Eiji Negishi, Misako Imachi and Takao Hashimoto
      Drug Metabolism and Disposition June 2001, 29 (6) 903-907;

  3. Imaoka, Susumu

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

J

  1. Johnson, Lisa M.

    1. Consumption of Watercress Fails to Alter Coumarin Metabolism in Humans
      Sharon E. Murphy, Lisa M. Johnson, London M. Losey, Steven G. Carmella and Stephen S. Hecht
      Drug Metabolism and Disposition June 2001, 29 (6) 786-788;

K

  1. Kamataki, Tetsuya

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  2. Kaminsky, Laurence S.

    1. CYP1B1 Expression in Human Lung
      Simon D. Spivack, Gregory J. Hurteau, Andrew A. Reilly, Kenneth M. Aldous, Xinxin Ding and Laurence S. Kaminsky
      Drug Metabolism and Disposition June 2001, 29 (6) 916-922;

  3. Kariya, Satoru

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

  4. Kassahun, Kelem

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  5. Kawalek, Joseph C.

    1. Identification of Multiple Constitutive and Inducible Hepatic Cytochrome P450 Enzymes in Market Weight Swine
      Michael J. Myers, Dorothy E. Farrell, Karyn D. Howard and Joseph C. Kawalek
      Drug Metabolism and Disposition June 2001, 29 (6) 908-915;

  6. Kemper, Raymond A.

    1. Metabolism of Butadiene Monoxide by Freshly Isolated Hepatocytes from Mice and Rats: Different Partitioning between Oxidative, Hydrolytic, and Conjugation Pathways
      Raymond A. Kemper, Renee J. Krause and Adnan A. Elfarra
      Drug Metabolism and Disposition June 2001, 29 (6) 830-836;

  7. Kilicarslan, Tansel

    1. Evaluation of Methoxsalen, Tranylcypromine, and Tryptamine as Specific and Selective CYP2A6 Inhibitors in Vitro
      Wenjiang Zhang, Tansel Kilicarslan, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2001, 29 (6) 897-902;

  8. Komatsu, Tomoko

    1. Rat Cytochrome P450 1A and 3A Enzymes Involved in Bioactivation of Tegafur to 5-Fluorouracil and Autoinduced by Tegafur in Liver Microsomes
      Hiroshi Yamazaki, Tomoko Komatsu, Kei Takemoto, Noriaki Shimada, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2001, 29 (6) 794-797;

  9. Krause, Renee J.

    1. Metabolism of Butadiene Monoxide by Freshly Isolated Hepatocytes from Mice and Rats: Different Partitioning between Oxidative, Hydrolytic, and Conjugation Pathways
      Raymond A. Kemper, Renee J. Krause and Adnan A. Elfarra
      Drug Metabolism and Disposition June 2001, 29 (6) 830-836;

  10. Kronbach, Thomas

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

  11. Kupfer, D.

    1. Mechanism of Induction of Cytochrome P450 Enzymes by the Proestrogenic Endocrine Disruptor Pesticide-Methoxychlor: Interactions of Methoxychlor Metabolites with the Constitutive Androstane Receptor System
      D. Blizard, T. Sueyoshi, M. Negishi, S. S. Dehal and D. Kupfer
      Drug Metabolism and Disposition June 2001, 29 (6) 781-785;

L

  1. Lee, Mao-Jung

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  2. Li, Chuan

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  3. Lin, Chin-chung

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

  4. Losey, London M.

    1. Consumption of Watercress Fails to Alter Coumarin Metabolism in Humans
      Sharon E. Murphy, Lisa M. Johnson, London M. Losey, Steven G. Carmella and Stephen S. Hecht
      Drug Metabolism and Disposition June 2001, 29 (6) 786-788;

M

  1. Madyastha, Madhava K.

    1. Effect of Ring Size in R-(+)-Pulegone-Mediated Hepatotoxicity: Studies on the Metabolism ofR-(+)-4-Methyl-2-(1-Methylethylidene)-Cyclopentanone anddl-Camphorone in Rats
      Hirekodathakallu V. Thulasiram, Vadiraja B. Bhat and Madhava K. Madyastha
      Drug Metabolism and Disposition June 2001, 29 (6) 821-829;

  2. Marty, Jean-Paul

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

  3. Matsumoto, Satoshi

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  4. McIntosh, Ian S.

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  5. Meijer, Dirk K. F.

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

  6. Melgert, Barbro N.

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

  7. Meng, Xiaofeng

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  8. Mise, Masashi

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  9. Mishin, Vladimir M.

    1. Clotrimazole is a Selective and Potent Inhibitor of Rat Cytochrome P450 3A Subfamily-Related Testosterone Metabolism
      Valerie K. Turan, Vladimir M. Mishin and Paul E. Thomas
      Drug Metabolism and Disposition June 2001, 29 (6) 837-842;

  10. Miyazaki, Hisashi

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  11. Murphy, Patrick J.

    1. Xenobiotic Metabolism: A Look from the Past to the Future
      Patrick J. Murphy
      Drug Metabolism and Disposition June 2001, 29 (6) 779-780;

  12. Murphy, Sharon E.

    1. Consumption of Watercress Fails to Alter Coumarin Metabolism in Humans
      Sharon E. Murphy, Lisa M. Johnson, London M. Losey, Steven G. Carmella and Stephen S. Hecht
      Drug Metabolism and Disposition June 2001, 29 (6) 786-788;

  13. Myers, Michael J.

    1. Identification of Multiple Constitutive and Inducible Hepatic Cytochrome P450 Enzymes in Market Weight Swine
      Michael J. Myers, Dorothy E. Farrell, Karyn D. Howard and Joseph C. Kawalek
      Drug Metabolism and Disposition June 2001, 29 (6) 908-915;

N

  1. Nakajima, Miki

    1. Rat Cytochrome P450 1A and 3A Enzymes Involved in Bioactivation of Tegafur to 5-Fluorouracil and Autoinduced by Tegafur in Liver Microsomes
      Hiroshi Yamazaki, Tomoko Komatsu, Kei Takemoto, Noriaki Shimada, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2001, 29 (6) 794-797;

  2. Negishi, Eiji

    1. Direct Nuclear Magnetic Resonance Spectroscopic Analysis of 13C-Labeled Antipyrine Metabolites in Human Urine
      Kazuki Akira, Eiji Negishi, Misako Imachi and Takao Hashimoto
      Drug Metabolism and Disposition June 2001, 29 (6) 903-907;

  3. Negishi, M.

    1. Mechanism of Induction of Cytochrome P450 Enzymes by the Proestrogenic Endocrine Disruptor Pesticide-Methoxychlor: Interactions of Methoxychlor Metabolites with the Constitutive Androstane Receptor System
      D. Blizard, T. Sueyoshi, M. Negishi, S. S. Dehal and D. Kupfer
      Drug Metabolism and Disposition June 2001, 29 (6) 781-785;

  4. Ngui, Jason S.

    1. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  5. Nomeir, Amin A.

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

  6. Norton, Laura A.

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

O

  1. Ogawa, Naoyoshi

    1. Identification of Rat Urinary and Biliary Metabolites of Esonarimod, a Novel Antirheumatic Drug, Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry with Postcolumn Addition of 2-(2-Methoxyethoxy)Ethanol, a Signal-Enhancing Modifier
      Jun-Ichi Yamaguchi, Mari Ohmichi, Masatoshi Hasegawa, Hideo Yoshida, Naoyoshi Ogawa and Shohei Higuchi
      Drug Metabolism and Disposition June 2001, 29 (6) 806-812;

  2. Ohmichi, Mari

    1. Identification of Rat Urinary and Biliary Metabolites of Esonarimod, a Novel Antirheumatic Drug, Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry with Postcolumn Addition of 2-(2-Methoxyethoxy)Ethanol, a Signal-Enhancing Modifier
      Jun-Ichi Yamaguchi, Mari Ohmichi, Masatoshi Hasegawa, Hideo Yoshida, Naoyoshi Ogawa and Shohei Higuchi
      Drug Metabolism and Disposition June 2001, 29 (6) 806-812;

  3. Ohtani, Michiteru

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

  4. Olinga, Peter

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

P

  1. Palamanda, Jairam R.

    1. Mechanism-Based Inactivation of CYP2D6 by 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine
      Jairam R. Palamanda, Christopher N. Casciano, Laura A. Norton, Robert P. Clement, Leonard V. Favreau, Chin-chung Lin and Amin A. Nomeir
      Drug Metabolism and Disposition June 2001, 29 (6) 863-867;

  2. Payan, Jean-Paul

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

  3. Payan, Jean Paul

    1. Toxicokinetics and Metabolism of 1,2-Diethylbenzene in Male Sprague Dawley Rats—Part 2: Evidence for in Vitro and in Vivo Stereoselectivity of 1,2-Diethylbenzene Metabolism
      Jean Paul Payan, Benoit Cossec, Dominique Beydon, Jean Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition June 2001, 29 (6) 868-876;

  4. Peter, Gernot

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

  5. Poelstra, Klaas

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

R

  1. Reilly, Andrew A.

    1. CYP1B1 Expression in Human Lung
      Simon D. Spivack, Gregory J. Hurteau, Andrew A. Reilly, Kenneth M. Aldous, Xinxin Ding and Laurence S. Kaminsky
      Drug Metabolism and Disposition June 2001, 29 (6) 916-922;

  2. Rodeheffer, Carey

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  3. Rodrigues, A. David

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

S

  1. Sang, Shengmin

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  2. Schaber, Gisela

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

  3. Schupke, Hubert

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

  4. Sellers, Edward M.

    1. Evaluation of Methoxsalen, Tranylcypromine, and Tryptamine as Specific and Selective CYP2A6 Inhibitors in Vitro
      Wenjiang Zhang, Tansel Kilicarslan, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2001, 29 (6) 897-902;

  5. Sheng, Shuqun

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  6. Shimada, Noriaki

    1. Rat Cytochrome P450 1A and 3A Enzymes Involved in Bioactivation of Tegafur to 5-Fluorouracil and Autoinduced by Tegafur in Liver Microsomes
      Hiroshi Yamazaki, Tomoko Komatsu, Kei Takemoto, Noriaki Shimada, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2001, 29 (6) 794-797;

  7. Shou, Magang

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;
    2. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  8. Slaughter, Donald E.

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  9. Slooff, Maarten J. H.

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

  10. Spivack, Simon D.

    1. CYP1B1 Expression in Human Lung
      Simon D. Spivack, Gregory J. Hurteau, Andrew A. Reilly, Kenneth M. Aldous, Xinxin Ding and Laurence S. Kaminsky
      Drug Metabolism and Disposition June 2001, 29 (6) 916-922;

  11. Stearns, Ralph A.

    1. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  12. Sueyoshi, T.

    1. Mechanism of Induction of Cytochrome P450 Enzymes by the Proestrogenic Endocrine Disruptor Pesticide-Methoxychlor: Interactions of Methoxychlor Metabolites with the Constitutive Androstane Receptor System
      D. Blizard, T. Sueyoshi, M. Negishi, S. S. Dehal and D. Kupfer
      Drug Metabolism and Disposition June 2001, 29 (6) 781-785;

T

  1. Takemoto, Kei

    1. Rat Cytochrome P450 1A and 3A Enzymes Involved in Bioactivation of Tegafur to 5-Fluorouracil and Autoinduced by Tegafur in Liver Microsomes
      Hiroshi Yamazaki, Tomoko Komatsu, Kei Takemoto, Noriaki Shimada, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2001, 29 (6) 794-797;

  2. Tang, Wei

    1. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  3. Terauchi, Yoshiaki

    1. A Novel Cytochrome P450 Enzyme Responsible for the Metabolism of Ebastine in Monkey Small Intestine
      Takanori Hashizume, Masashi Mise, Satoshi Matsumoto, Yoshiaki Terauchi, Toshihiko Fujii, Susumu Imaoka, Yoshihiko Funae, Tetsuya Kamataki and Hisashi Miyazaki
      Drug Metabolism and Disposition June 2001, 29 (6) 798-805;

  4. Thomas, Paul E.

    1. Clotrimazole is a Selective and Potent Inhibitor of Rat Cytochrome P450 3A Subfamily-Related Testosterone Metabolism
      Valerie K. Turan, Vladimir M. Mishin and Paul E. Thomas
      Drug Metabolism and Disposition June 2001, 29 (6) 837-842;

  5. Thulasiram, Hirekodathakallu V.

    1. Effect of Ring Size in R-(+)-Pulegone-Mediated Hepatotoxicity: Studies on the Metabolism ofR-(+)-4-Methyl-2-(1-Methylethylidene)-Cyclopentanone anddl-Camphorone in Rats
      Hirekodathakallu V. Thulasiram, Vadiraja B. Bhat and Madhava K. Madyastha
      Drug Metabolism and Disposition June 2001, 29 (6) 821-829;

  6. Turan, Valerie K.

    1. Clotrimazole is a Selective and Potent Inhibitor of Rat Cytochrome P450 3A Subfamily-Related Testosterone Metabolism
      Valerie K. Turan, Vladimir M. Mishin and Paul E. Thomas
      Drug Metabolism and Disposition June 2001, 29 (6) 837-842;

  7. Tyndale, Rachel F.

    1. Evaluation of Methoxsalen, Tranylcypromine, and Tryptamine as Specific and Selective CYP2A6 Inhibitors in Vitro
      Wenjiang Zhang, Tansel Kilicarslan, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2001, 29 (6) 897-902;

U

  1. Uchino, Katsuyoshi

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

V

  1. Vincent, Claire Marie

    1. In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat
      Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude and Claire Marie Vincent
      Drug Metabolism and Disposition June 2001, 29 (6) 843-854;

W

  1. Wachsmuth, Helmut

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

  2. Walsh, Deborah J.

    1. Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor
      Kelem Kassahun, Ian S. McIntosh, Magang Shou, Deborah J. Walsh, Carey Rodeheffer, Donald E. Slaughter, Leslie A. Geer, Rita A. Halpin, Nancy Agrawal and A. David Rodrigues
      Drug Metabolism and Disposition June 2001, 29 (6) 813-820;

  3. Wang, Regina W.

    1. In Vitro Stimulation of Warfarin Metabolism by Quinidine: Increases in the Formation of 4′- and 10-Hydroxywarfarin
      Jason S. Ngui, Qing Chen, Magang Shou, Regina W. Wang, Ralph A. Stearns, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition June 2001, 29 (6) 877-886;

  4. Weert, Betty

    1. Cellular Distribution and Handling of Liver-Targeting Preparations in Human Livers Studied by a Liver Lobe Perfusion
      Barbro N. Melgert, Peter Olinga, Betty Weert, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra and Geny M. M. Groothuis
      Drug Metabolism and Disposition June 2001, 29 (6) 361-367;

  5. Wessel, Klaus

    1. New Metabolic Pathways of α-Lipoic Acid
      Hubert Schupke, Roland Hempel, Gernot Peter, Robert Hermann, Klaus Wessel, Jürgen Engel and Thomas Kronbach
      Drug Metabolism and Disposition June 2001, 29 (6) 855-862;

  6. Wiatr, Gerlinde

    1. Isolation and Identification of Clozapine Metabolites in Patient Urine
      Gisela Schaber, Gerlinde Wiatr, Helmut Wachsmuth, Markus Dachtler, Klaus Albert, Ines Gaertner and Ursula Breyer-Pfaff
      Drug Metabolism and Disposition June 2001, 29 (6) 923-931;

Y

  1. Yamaguchi, Jun-Ichi

    1. Identification of Rat Urinary and Biliary Metabolites of Esonarimod, a Novel Antirheumatic Drug, Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry with Postcolumn Addition of 2-(2-Methoxyethoxy)Ethanol, a Signal-Enhancing Modifier
      Jun-Ichi Yamaguchi, Mari Ohmichi, Masatoshi Hasegawa, Hideo Yoshida, Naoyoshi Ogawa and Shohei Higuchi
      Drug Metabolism and Disposition June 2001, 29 (6) 806-812;

  2. Yamamura, Yoshikazu

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

  3. Yamazaki, Hiroshi

    1. Rat Cytochrome P450 1A and 3A Enzymes Involved in Bioactivation of Tegafur to 5-Fluorouracil and Autoinduced by Tegafur in Liver Microsomes
      Hiroshi Yamazaki, Tomoko Komatsu, Kei Takemoto, Noriaki Shimada, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2001, 29 (6) 794-797;

  4. Yanagihara, Yoshitsugu

    1. Involvement of CYP2B6 in N-Demethylation of Ketamine in Human Liver Microsomes
      Yoshitsugu Yanagihara, Satoru Kariya, Michiteru Ohtani, Katsuyoshi Uchino, Takao Aoyama, Yoshikazu Yamamura and Tatsuji Iga
      Drug Metabolism and Disposition June 2001, 29 (6) 887-890;

  5. Yang, Chung S.

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;

  6. Yokoi, Tsuyoshi

    1. Rat Cytochrome P450 1A and 3A Enzymes Involved in Bioactivation of Tegafur to 5-Fluorouracil and Autoinduced by Tegafur in Liver Microsomes
      Hiroshi Yamazaki, Tomoko Komatsu, Kei Takemoto, Noriaki Shimada, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2001, 29 (6) 794-797;

  7. Yoshida, Hideo

    1. Identification of Rat Urinary and Biliary Metabolites of Esonarimod, a Novel Antirheumatic Drug, Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry with Postcolumn Addition of 2-(2-Methoxyethoxy)Ethanol, a Signal-Enhancing Modifier
      Jun-Ichi Yamaguchi, Mari Ohmichi, Masatoshi Hasegawa, Hideo Yoshida, Naoyoshi Ogawa and Shohei Higuchi
      Drug Metabolism and Disposition June 2001, 29 (6) 806-812;

Z

  1. Zhang, Wenjiang

    1. Evaluation of Methoxsalen, Tranylcypromine, and Tryptamine as Specific and Selective CYP2A6 Inhibitors in Vitro
      Wenjiang Zhang, Tansel Kilicarslan, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2001, 29 (6) 897-902;

  2. Zhu, Nanqun

    1. Formation and Identification of 4′-O-Methyl-(−)-Epigallocatechin in Humans
      Xiaofeng Meng, Mao-Jung Lee, Chuan Li, Shuqun Sheng, Nanqun Zhu, Shengmin Sang, Chi-Tang Ho and Chung S. Yang
      Drug Metabolism and Disposition June 2001, 29 (6) 789-793;
Back to top

In this issue